Karah Herdman Parschauer
Director; EVP and Chief Legal Officer · 2 filings · Latest: May 28, 2026
Tenaya Therapeutics, Inc.
Ultragenyx Pharmaceutical Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | Apr 16, 2026 | Grant/Award | $0.00 | 28,895 | — | 95,715 |